Industry: Technology Products
Themes: Artificial Intelligence, Digital Transformation, Enterprise Software, Healthcare
Transaction Type:
Strategic equity investment and partnership.
Transaction Objective:
The partnership is intended to advance and accelerate the adoption of AI-driven solutions in life & health (L&H) underwriting, claims management, and risk assessment processes. By leveraging Xceedance’s deep industry footprint and Friendly’s deep-learning data analysis technology, the two companies plan to co-develop joint initiatives and expand AI capabilities across the global insurance lifecycle.
Transaction Date:
This transaction was made on March 26, 2025
Investor and Recipient Information
Recipient Name:
Strategic equity investment and partnership.
Recipient Information:
The partnership is intended to advance and accelerate the adoption of AI-driven solutions in life & health (L&H) underwriting, claims management, and risk assessment processes. By leveraging Xceedance’s deep industry footprint and Friendly’s deep-learning data analysis technology, the two companies plan to co-develop joint initiatives and expand AI capabilities across the global insurance lifecycle.
Investor Name:
Strategic equity investment and partnership.
Investor Information:
The partnership is intended to advance and accelerate the adoption of AI-driven solutions in life & health (L&H) underwriting, claims management, and risk assessment processes. By leveraging Xceedance’s deep industry footprint and Friendly’s deep-learning data analysis technology, the two companies plan to co-develop joint initiatives and expand AI capabilities across the global insurance lifecycle.
Confidentiality Notice
No restrictive confidentiality markings, disclaimers, or copyright watermarks are visible on the provided graphic. Both companies widely publicized this strategic investment via public press releases and media distribution.